Contravisory Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oneok
OKE
|
+$6M |
| 2 |
Eli Lilly
LLY
|
+$5.91M |
| 3 |
Elevance Health
ELV
|
+$5.9M |
| 4 |
Entergy
ETR
|
+$5.78M |
| 5 |
Edison International
EIX
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRMN
Garmin
GRMN
|
+$8.98M |
| 2 |
Trex
TREX
|
+$8.74M |
| 3 |
Target
TGT
|
+$8.54M |
| 4 |
JPMorgan Chase
JPM
|
+$5.65M |
| 5 |
Lear
LEA
|
+$5.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.77% |
| 2 | Healthcare | 14.81% |
| 3 | Energy | 13.36% |
| 4 | Technology | 12.51% |
| 5 | Real Estate | 8.38% |
Similar funds
Contravisory Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, Contravisory Investment Management held 389 positions worth $352M, down 4.9% from $371M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Contravisory Investment Management withdrew a net $17.4M in Q1 2022, closing 59 positions and reducing 115 holdings. Its most notable exit was Garmin, an estimated $8.98M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Contravisory Investment Management opened a new position in Oneok worth $6.62M.
- Contravisory Investment Management's largest Q1 2022 buy was Oneok: 93,736 shares worth $6.62M.
- Contravisory Investment Management added most to Elevance Health in Q1 2022, an estimated $5.9M increase.
- Contravisory Investment Management's biggest Q1 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $428K.
- Contravisory Investment Management fully exited Garmin in Q1 2022, selling an estimated $8.98M.
- Contravisory Investment Management's ten largest holdings make up 26% of its $352M portfolio in Q1 2022.
- Contravisory Investment Management opened 108 new positions and closed 59 in Q1 2022.
- Contravisory Investment Management's portfolio value fell 4.9% quarter-over-quarter to $352M.
Based on Contravisory Investment Management's 13F filing for Q1 2022, filed 8 Apr 2022.